Treatment of severe primary IGF-1 deficiency using rhIGF-1 preparation - first three years of Polish experience.
CONCLUSIONS: Treatment with rhIGF-1 was effective and safe in Polish patients with primary IGF-1 deficiency. It had a clear beneficial effect on the height of the patients and significantly accelerated the height velocity, particularly in the first year of treatment.
PMID: 30351442 [PubMed - as supplied by publisher]
Source: Endokrynologia Polska - Category: Endocrinology Authors: Petriczko E, Jackowski T, Horodnicka-Józwa A, Wikiera B, Noczyńska A, Korpal-Szczyrska M, Birkholz-Walerzak D, Małecka-Tendera E, Kalina-Fraska B, Kalina M, Barg E, Beń-Skowronek I, Szewczyk L, Hilczer M, Smyczyńska J, Stawerska R, Lewiński A, Ziora Tags: Endokrynol Pol Source Type: research
More News: Boys | Children | Endocrinology | Girls | Hormones | Insulin | Poland Health | Statistics | Study | Wikis